Parallel Advisors, LLC Aurinia Pharmaceuticals Inc. Transaction History

Parallel Advisors, LLC

$4.34 Billion
Q4 2024

A detailed history of Parallel Advisors, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 43 shares of AUPH stock, worth $334. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$334

% of portfolio

0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 10, 2025	BUY	$6.75 - $10.44 $290 - $448	43 New	43 $0
Q4 2023 Feb 09, 2024	BUY	$7.13 - $9.49 $85 - $113	12 New	12 $0
Q2 2021 Aug 06, 2021	SELL	$10.0 - $14.52 $21,500 - $31,218	-2,150 Closed	0 $0
Q1 2021 Apr 23, 2021	SELL	$12.3 - $18.73 $24,600 - $37,460	-2,000 Reduced 48.19%	2,150 $28,000
Q4 2020 Feb 02, 2021	BUY	$12.94 - $16.05 $52,795 - $65,484	4,080 Added 5828.57%	4,150 $57,000
Q3 2020 Oct 27, 2020	BUY	$13.19 - $16.66 $923 - $1,166	70 New	70 $1,000
Q4 2019 Jan 30, 2020	SELL	$3.88 - $21.42 $9,700 - $53,550	-2,500 Closed	0 $0
Q3 2019 Nov 01, 2019	BUY	$5.34 - $6.59 $2,670 - $3,295	500 Added 25.0%	2,500 $13,000
Q4 2018 Feb 05, 2019	BUY	$5.08 - $6.83 $5,080 - $6,830	1,000 Added 100.0%	2,000 $13,000
Q3 2018 Nov 01, 2018	BUY	$5.27 - $6.64 $2,635 - $3,320	500 Added 100.0%	1,000 $7,000
Q2 2018 Jul 30, 2018	SELL	$5.06 - $6.36 $7,589 - $9,540	-1,500 Reduced 75.0%	500 $2,000
Q1 2018 May 08, 2018	SELL	$4.85 - $5.99 $14,549 - $17,970	-3,000 Reduced 60.0%	2,000 $10,000
Q4 2017 Feb 13, 2018	BUY	$4.53 - $7.09 $13,590 - $21,270	3,000 Added 150.0%	5,000 $23,000
Q3 2017 Nov 15, 2017	BUY	$5.71 - $6.9 $11,420 - $13,800	2,000 New	2,000 $11,000
Q3 2017 Nov 14, 2017	SELL	$5.71 - $6.9 $28,550 - $34,500	-5,000 Closed	0 $0
Q2 2017 Aug 07, 2017	BUY	N/A	5,000	5,000 $32,000

Others Institutions Holding AUPH

# of Institutions

230

Shares Held

59M

Call Options Held

Put Options Held

1.61M

Black Rock Inc. New York, NY

9.27M
Shares

$72.2 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

8.43M
Shares

$65.7 Million
5.69% of portfolio
Armistice Capital, LLC New York, NY

6.4M
Shares

$49.9 Million
0.81% of portfolio
Nea Management Company, LLC Timonium, MD

3.97M
Shares

$30.9 Million
2.55% of portfolio
State Street Corp Boston, MA

2.92M
Shares

$22.7 Million
0.0% of portfolio

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.11B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Account